Literature DB >> 4549499

Tuberculin sensitivity and skin lesions in children after vaccination with 11 different BCG strains.

R S Vallishayee, A N Shashidhara, K Bunch-Christensen, J Guld.   

Abstract

In previously published studies, a number of BCG strains used in several production laboratories were compared in animal models. Liquid vaccines from the different strains were prepared in one laboratory with a uniform technique, the aim being to obtain uniform in vitro properties. In the studies reported here, such vaccines were compared by means of vaccinating children in India and Denmark and then measuring their post-vaccination skin lesions and tuberculin sensitivity. One strain induced delayed hypersensitivity strikingly weaker than that induced by any of the others, although the vaccine was in no way inferior in terms of exhaustive in vitro tests. Differences among the other strains were slight, although sometimes statistically significant. The implications of such differences are discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4549499      PMCID: PMC2366314     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  The virulence of some strains of BCG for golden hamsters.

Authors:  K Bunch-Christensen; A Ladefoged; J Guld
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

  1 in total
  8 in total

1.  Tuberculin sensitivity among children vaccinated with BCG under universal immunization programme.

Authors:  V K Chadha; P S Jaganath; P Kumar
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

2.  Tuberculin sensitivity in guinea-pigs after vaccination with varying doses of BCG of 12 different strains.

Authors:  A Ladefoged; K Bunch-Christensen; J Guld
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

3.  Trial of BCG vaccines in south India for tuberculosis prevention: first report--Tuberculosis Prevention Trial.

Authors: 
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

4.  BCG vaccine in Korea.

Authors:  Sun Myung Joung; Sungweon Ryoo
Journal:  Clin Exp Vaccine Res       Date:  2013-07-03

5.  The association between Bacillus Calmette-Guérin vaccination (1331 SSI) skin reaction and subsequent scar development in infants.

Authors:  Nina Marie Birk; Thomas Nørrelykke Nissen; Monica Ladekarl; Vera Zingmark; Jesper Kjærgaard; Trine Mølbæk Jensen; Signe Kjeldgaard Jensen; Lisbeth Marianne Thøstesen; Poul-Erik Kofoed; Lone Graff Stensballe; Andreas Andersen; Ole Pryds; Susanne Dam Nielsen; Christine Stabell Benn; Dorthe Lisbeth Jeppesen
Journal:  BMC Infect Dis       Date:  2017-08-03       Impact factor: 3.090

6.  Determinants of Bacille Calmette-Guérin scarification in Danish children.

Authors:  Trine Mølbæk Jensen; Signe Kjeldgaard Jensen; Nina Marie Birk; Andreas Rieckmann; Thomas Hoffmann; Christine Stabell Benn; Dorthe Lisbeth Jeppesen; Ole Pryds; Thomas Nørrelykke Nissen
Journal:  Heliyon       Date:  2021-01-04

7.  Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.

Authors:  Andrea S Leung; Vanessa Tran; Zuowei Wu; Xuping Yu; David C Alexander; George Fu Gao; Baoli Zhu; Jun Liu
Journal:  BMC Genomics       Date:  2008-09-15       Impact factor: 3.969

8.  Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection against Tuberculosis.

Authors:  Sang Kyun Ahn; Vanessa Tran; Andrea Leung; Mark Ng; Ming Li; Jun Liu
Journal:  Mol Ther       Date:  2018-09-01       Impact factor: 11.454

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.